Clinical Trials, Phase IV as Topic [klinické zkoušky, fáze IV jako téma]
- Terms
-
evaluační studie, FDA fáze IV
klinické hodnocení fáze IV
klinické hodnocení léčiv, fáze IV
klinické hodnocení léčiv, FDA fáze IV
klinické zkoušky - fáze IV - jako téma
-
Clinical Trials, Phase 4 as Topic
Drug Evaluation, FDA Phase 4 as Topic
Drug Evaluation, FDA Phase IV as Topic
Evaluation Studies, FDA Phase 4 as Topic
Evaluation Studies, FDA Phase IV as Topic
Works about planned post-marketing studies of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale. These studies are often conducted to obtain additional data about the safety and efficacy of a product. This concept includes phase IV studies conducted in both the U.S. and in other countries.
- Annotation
- for general design, methodology, economics, etc. of phase IV clinical trials; a different heading CLINICAL TRIAL, PHASE IV is used for reports of a specific phase IV clinical trial
- DUI
- D017327 MeSH Browser
- CUI
- M0026314
- Previous indexing
- Clinical Trials (1980-1992)
- History note
- 2008(1993)
- Public note
- 2008; see CLINICAL TRIALS, PHASE IV 1993-2007; for DRUG EVALUATION, FDA PHASE IV see CLINICAL TRIALS 1981-1992; for EVALUATION STUDIES, FDA PHASE IV see CLINICAL TRIALS 1982-1992
Allowable subheadings
- CL
- classification 1
- EC
- economics
- ES
- ethics 1
- HI
- history
- IS
- instrumentation
- LJ
- legislation & jurisprudence
- MT
- methods 5
- PX
- psychology
- ST
- standards 1
- SN
- statistics & numerical data 3
- VE
- veterinary